Please login to the form below
Pharmaceutical Market Europe (PME)
PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
Novartis gets EU approval for multiple sclerosis therapy Mayzent
Offers subgroup of patients an important new treatment option
J&J wins another label expansion for Darzalex in Europe
Multiple myeloma treatment indicated for early use
EU grants conditional approval to Roche's lymphoma drug Polivy
Drug demonstrated a 40% complete response rate in trial
Immuno-oncology, personalised medicine continues to drive pharma sector
New GlobalData survey identifies key trends impacting the industry
Articles
-
The changing nature of approvals – what does the future hold?The 2019 CMR International Pharmaceutical R&D Factbook
-
20/20 visionPredicting the year ahead for healthcare communications
-
Integrating electronic health records into clinical trialsHow organisations are working to realise the research potential of EHRs
-
Keeping up the fight against HIV and using the lessons to tackle other threatsDanny Buckland interviews Gilead’s Mike Elliott
-
Growing up as a patient is hard to manageBy Clare Moloney
Pharmaceutical Market Europe - January 2020
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Editor - Iona Everson
Have your say...
Subscribe
Biogen just can’t quit Alzheimer’s, licensing another drug from Pfizer
Snaps up clinical-stage candidate for $75m upfront
'Nothing about us without us'
Why patient engagement is essential throughout the entire product life cycle
Featured jobs
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Consultant
-
competitive salary
- Account Director or Senior Account Director
-
Salary TBC
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
-
Vice President
-
Competitive Salary Offered
- Senior Medical Writer, MedComms Agency
-
Salary TBC
Subscribe to our email news alerts
- My Journey into Medical Communications #LucidLife
- Novartis gets EU approval for multiple sclerosis therapy Mayzent
- J&J wins another label expansion for Darzalex in Europe
- EU grants conditional approval to Roche's lymphoma drug Polivy
- Immuno-oncology, personalised medicine continues to drive pharma sector
- OPEN Health expands offering with the launch of a new Learning & Development specialist team
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- OPEN Health expands offering with the launch of a new Learning & Development specialist team
- Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
- The changing nature of approvals – what does the future hold?
- The 2019 CMR International Pharmaceutical R&D Factbook...
- Spotlight interview: 15 minutes on healthcare communications in gene therapy
- Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy...
Quick links
Infographics
